Ice baths are everywhere in modern fitness culture. From professional athletes to weekend warriors, many swear by the post-workout plunge, hoping the icy shock will ease soreness, calm inflammation ...

New research compared the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. Here's what the study ...

Rosemary Shrager has opened up about the secret behind her incredible weight loss journey after weighing 20 stone at her ...

We thank those who flagged outdated information on our website, and have made those updates. We believe in providing the highest quality training for ALL medical school candidates or graduates ...

What is it? A medication called semaglutide, which is sold under different brand names, including Ozempic, approved in 2017 for treating type 2 diabetes, and Wegovy, approved just last year for ...

Despite the rising popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, many still prefer drug-free methods. Research indicates that dietary strategies, such as increasing fiber ...

Ozempic (semaglutide) belongs to a group of medications called GLP-1 receptor agonists that help treat type 2 diabetes. This medication is a once-weekly injection that helps regulate blood sugar ...

The "Semaglutide Market Size, Share & Trends Analysis Report by Product (Ozempic, Wegovy, Rybelsus), Application (Type 2 Diabetes Mellitus, Obesity), Route of Administration, Distribution Channel, ...

PLAINSBORO, N.J., May 22, 2025 /PRNewswire/ -- Today, as the US Food and Drug Administration (FDA) grace period for mass compounding of "semaglutide" expires, Novo Nordisk announced a series of ...

Patients from New York and New Jersey have claimed that they suffered non-arteritic anterior ischemic optic neuropathy after taking drugs containing semaglutide — the active ingredient in ...

The allegations come amid several recent studies showing a link between vision complications and people taking drugs containing semaglutide, the active ingredient in Ozempic, Wegovy and Rybelsus ...

In a head-to-head diet-induced obese (DIO) mouse model, low dose ASC47 in combination with semaglutide demonstrated a 56.7% greater reduction in body weight with muscle preservation compared to ...